GeneDx Holdings Corp. - SIC # 8071 - MEDICAL LABORATORIES

Ticker Exchange SIC # Website Latest Ticker
WGS Nasdaq 8071 www.genedx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for GeneDx Holdings Corp.

Top Stock Picks for Week of August 24, 2026 - Aug 24th, 2026 1:07 pm
GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s - Aug 24th, 2026 6:30 am
Can GENEDX HOLDINGS (WGS) Run Higher on Rising Earnings Estimates? - Aug 19th, 2026 10:20 am
GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy - Aug 11th, 2026 6:30 am
GeneDx (WGS) Q2 2026 Earnings Call Transcript - Aug 10th, 2026 7:46 pm
GeneDx Holdings (WGS) Is Up 18.4% After Reaffirming 2026 Outlook And Raising Equity From Blackstone - Aug 7th, 2026 7:12 pm
GeneDx to Participate in Upcoming Investor Conferences - Aug 6th, 2026 2:05 pm
GeneDx Holdings Corp. Q2 2026 Earnings Call Summary - Aug 4th, 2026 6:30 am
GeneDx Holdings Corp (WGS) (Q2 2026) Earnings Call Highlights: Record Volume and Early ... - Aug 3rd, 2026 11:07 pm
GeneDx Q2 Earnings Call Highlights - Aug 3rd, 2026 5:03 pm
GeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Surpass Estimates - Aug 3rd, 2026 3:45 pm
GeneDx Reports Second Quarter 2026 Financial Results - Aug 3rd, 2026 2:05 pm
GeneDx Holdings Corp. (WGS) Slid as Revenue Fell Short of Expectations - Jul 21st, 2026 8:04 am
GeneDx Holdings Corp. (WGS) Fell Following a Significant Cut in 2026 Guidance - Jul 17th, 2026 7:11 am
GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026 - Jul 16th, 2026 2:05 pm
What a $227,000 GeneDx Insider Sale Means as Revenue Climbs 17% - Jun 23rd, 2026 4:08 pm
GeneDx Names Mark Gardner President to Lead Its Next Phase of Scale and Growth - Jun 16th, 2026 6:30 am